Current status of transition medicine for 21-hydroxylase deficiency in Japan: from the perspective of pediatric endocrinologists-Reference-Cited by-同舟云学术

Current status of transition medicine for 21-hydroxylase deficiency in Japan: from the perspective of pediatric endocrinologists

Author:

Takasawa Kei¹,Nakamura-Utsunomiya Akari²,Amano Naoko³,Ishii Tomohiro³,Hasegawa Tomonobu³,Hasegawa Yukihiro⁴,Tajima Toshihiro⁵,Ida Shinobu⁶

Affiliation:

1. Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo 113-8510, Japan

2. Department of Pediatrics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima 734-8553, Japan

3. Department of Pediatrics, Keio University School of Medicine, Tokyo 160-8582, Japan

4. Division of Endocrinology and Metabolism, Tokyo Metropolitan Children’s Medical Center, Tokyo 183-8561, Japan

5. Department of Pediatrics, Jichi Medical University, Tochigi 329-0498, Japan

6. Department of Gastroenterology and Endocrinology, Osaka Women’s and Children’s Hospital, Osaka 594-1101, Japan

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

Reference22 articles.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献